Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

Erectile dysfunction (ED) is a common issue that affects millions of men, leading to a decline in quality of life and ...

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Central to the Hims pitch is the fact that many people, especially younger men, avoid regularly going to the doctor; a recent Cleveland Clinic survey found that less than a third of Millennial and ...

The Super Bowl spot is a strikingly dark, politicized way of getting at the company’s latest initiative: selling weight-loss drugs to both women and men. The ad also marks a pivot for the telehealth ...

Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%, and achieved a full year of operating and net income profitability. Despite strong fundamentals, HIMS stock price has ...

Financial giants have made a conspicuous bearish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 60 unusual trades. Delving into the details ...

Demand for discreet, convenient solutions in men's and women's health has always been there, waiting to be tapped. Part of what makes Hims "meme-worthy" is the viral-friendly nature of its offerings.

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the ...